Loomis, Sayles & Company’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261K Sell
1,243
-766
-38% -$193K ﹤0.01% 549
2025
Q4
$571K Buy
2,009
+1,632
+433% +$510K ﹤0.01% 504
2025
Q3
$116K Buy
377
+30
+9% +$9.4K ﹤0.01% 551
2025
Q2
$109K Buy
347
+29
+9% +$8.37K ﹤0.01% 555
2025
Q1
$84K Buy
+318
New +$86.1K ﹤0.01% 590
2024
Q1
Sell
-32
Closed -$7K 907
2023
Q4
$7K Sell
32
-85,527
-100% -$14.7M ﹤0.01% 850
2023
Q3
$13.6M Sell
85,559
-7,978
-9% -$1.79M 0.02% 289
2023
Q2
$27M Sell
93,537
-3,219
-3% -$978K 0.04% 209
2023
Q1
$30.9M Sell
96,756
-377
-0.4% -$112K 0.05% 174
2022
Q4
$28.6M Sell
97,133
-19,459
-17% -$5.37M 0.06% 179
2022
Q3
$26.7M Sell
116,592
-16,052
-12% -$4.02M 0.05% 180
2022
Q2
$28.9M Sell
132,644
-1,099
-0.8% -$250K 0.05% 176
2022
Q1
$35.6M Sell
133,743
-43,823
-25% -$10.8M 0.05% 195
2021
Q4
$47.2M Sell
177,566
-1,850
-1% -$537K 0.06% 158
2021
Q3
$51M Buy
179,416
+5,100
+3% +$1.45M 0.06% 140
2021
Q2
$47.9M Buy
174,316
+6,668
+4% +$1.81M 0.06% 155
2021
Q1
$43.7M Buy
167,648
+298
+0.2% +$79.8K 0.06% 173
2020
Q4
$42.8M Buy
167,350
+19,856
+13% +$4.93M 0.06% 152
2020
Q3
$34.9M Sell
147,494
-1,411
-0.9% -$297K 0.05% 147
2020
Q2
$28.9M Buy
148,905
+11,721
+9% +$2.24M 0.05% 166
2020
Q1
$22.7M Sell
137,184
-1,426
-1% -$261K 0.05% 147
2019
Q4
$23.7M Sell
138,610
-51,563
-27% -$8.59M 0.04% 188
2019
Q3
$31.4M Sell
190,173
-370,490
-66% -$52.1M 0.06% 138
2019
Q2
$66.9M Buy
560,663
+15,264
+3% +$1.56M 0.13% 73
2019
Q1
$51.9M Buy
545,399
+40,310
+8% +$3.46M 0.1% 80
2018
Q4
$40.1M Buy
505,089
+131,226
+35% +$11.1M 0.09% 81
2018
Q3
$39.6M Sell
373,863
-51,494
-12% -$4.82M 0.08% 101
2018
Q2
$36.5M Buy
425,357
+3,031
+0.7% +$272K 0.07% 123
2018
Q1
$36.6M Sell
422,326
-128,159
-23% -$9.96M 0.08% 119
2017
Q4
$38M Sell
550,485
-5,196
-0.9% -$341K 0.08% 131
2017
Q3
$30.6M Sell
555,681
-16,781
-3% -$916K 0.07% 176
2017
Q2
$29.4M Buy
572,462
+8,887
+2% +$386K 0.07% 174
2017
Q1
$24.3M Sell
563,575
-12,677
-2% -$544K 0.06% 209
2016
Q4
$21.7M Sell
576,252
-29,617
-5% -$1.1M 0.05% 245
2016
Q3
$24.8M Sell
605,869
-27,562
-4% -$1.09M 0.06% 201
2016
Q2
$19.2M Sell
633,431
-16,128
-2% -$502K 0.05% 280
2016
Q1
$21.5M Buy
649,559
+71,497
+12% +$2.24M 0.06% 237
2015
Q4
$21.9M Buy
578,062
+349,162
+153% +$11.8M 0.06% 249
2015
Q3
$5.93M Buy
+228,900
New +$6.94M 0.02% 475
2015
Q1
Sell
-434,384
Closed -$20M 762
2014
Q4
$20M Sell
434,384
-22,029
-5% -$942K 0.06% 332
2014
Q3
$16.8M Sell
456,413
-12,074
-3% -$441K 0.05% 381
2014
Q2
$18.6M Sell
468,487
-18,421
-4% -$708K 0.05% 377
2014
Q1
$23.1M Sell
486,908
-193,623
-28% -$8.57M 0.07% 299
2013
Q4
$25.2M Buy
680,531
+9,086
+1% +$336K 0.08% 255
2013
Q3
$24.3M Sell
671,445
-2,672
-0.4% -$89.7K 0.08% 258
2013
Q2
$21.2K Buy
+674,117
New +$19.1M 0.08% 276

Other funds holding PODD

Loomis, Sayles & Company's PODD Position: Q1 2026 in Review

Loomis, Sayles & Company reduced its Insulet (PODD) stake by 38% in Q1 2026, selling an estimated $193K and leaving 1,243 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Loomis, Sayles & Company first reported a position in PODD in Q2 2013 and has held it in 46 quarters since. The position peaked at $66.9M in Q2 2019. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Loomis, Sayles & Company held 1,243 shares of Insulet worth $261K as of Q1 2026.
  • Loomis, Sayles & Company sold 766 Insulet shares in Q1 2026, an estimated $193K.
  • Insulet made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q1 2026, its #549 holding.
  • Loomis, Sayles & Company first reported a position in Insulet in Q2 2013 and has held it in 46 quarters since.
  • Loomis, Sayles & Company's Insulet position peaked at $66.9M in Q2 2019.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.